EPRX
Price
$5.39
Change
+$0.03 (+0.56%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
192.12M
60 days until earnings call
NAGE
Price
$9.43
Change
+$0.11 (+1.18%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
750.48M
53 days until earnings call
Interact to see
Advertisement

EPRX vs NAGE

Header iconEPRX vs NAGE Comparison
Open Charts EPRX vs NAGEBanner chart's image
Eupraxia Pharmaceuticals
Price$5.39
Change+$0.03 (+0.56%)
Volume$436
Capitalization192.12M
Niagen Bioscience
Price$9.43
Change+$0.11 (+1.18%)
Volume$15.95K
Capitalization750.48M
EPRX vs NAGE Comparison Chart in %
Loading...
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EPRX vs. NAGE commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPRX is a Hold and NAGE is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (EPRX: $5.36 vs. NAGE: $9.32)
Brand notoriety: EPRX and NAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EPRX: 177% vs. NAGE: 89%
Market capitalization -- EPRX: $192.12M vs. NAGE: $750.48M
EPRX [@Biotechnology] is valued at $192.12M. NAGE’s [@Biotechnology] market capitalization is $750.48M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EPRX’s FA Score shows that 0 FA rating(s) are green whileNAGE’s FA Score has 1 green FA rating(s).

  • EPRX’s FA Score: 0 green, 5 red.
  • NAGE’s FA Score: 1 green, 4 red.
According to our system of comparison, NAGE is a better buy in the long-term than EPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EPRX’s TA Score shows that 5 TA indicator(s) are bullish while NAGE’s TA Score has 5 bullish TA indicator(s).

  • EPRX’s TA Score: 5 bullish, 4 bearish.
  • NAGE’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NAGE is a better buy in the short-term than EPRX.

Price Growth

EPRX (@Biotechnology) experienced а +1.71% price change this week, while NAGE (@Biotechnology) price change was -5.09% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.94%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

EPRX is expected to report earnings on Nov 05, 2025.

NAGE is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NAGE($750M) has a higher market cap than EPRX($192M). NAGE YTD gains are higher at: 75.683 vs. EPRX (69.085). NAGE has higher annual earnings (EBITDA): 18.1M vs. EPRX (-28.83M). NAGE has more cash in the bank: 60.3M vs. EPRX (19.8M). EPRX has less debt than NAGE: EPRX (35.1K) vs NAGE (3.29M). NAGE has higher revenues than EPRX: NAGE (116M) vs EPRX (0).
EPRXNAGEEPRX / NAGE
Capitalization192M750M26%
EBITDA-28.83M18.1M-159%
Gain YTD69.08575.68391%
P/E RatioN/A42.77-
Revenue0116M-
Total Cash19.8M60.3M33%
Total Debt35.1K3.29M1%
FUNDAMENTALS RATINGS
NAGE: Fundamental Ratings
NAGE
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
79
SMR RATING
1..100
25
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EPRXNAGE
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
71%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
43%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 8 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
41%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
EPRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RTOUX43.250.64
+1.50%
Russell Inv Tax-Managed US Mid&Sm Cap M
LSVQX19.900.25
+1.27%
LSV Small Cap Value Institutional
ASCYX11.180.10
+0.90%
Alger Small Cap Growth Y
MITBX35.950.29
+0.81%
MFS Massachusetts Investors Tr B
AMRCX5.320.04
+0.76%
American Growth One C

EPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, EPRX has been loosely correlated with NAGE. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if EPRX jumps, then NAGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EPRX
1D Price
Change %
EPRX100%
-0.74%
NAGE - EPRX
34%
Loosely correlated
-3.62%
IVEVF - EPRX
28%
Poorly correlated
N/A
ACAD - EPRX
28%
Poorly correlated
-0.86%
ETNB - EPRX
26%
Poorly correlated
-6.82%
MDGL - EPRX
26%
Poorly correlated
-0.93%
More

NAGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAGE has been loosely correlated with IRON. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if NAGE jumps, then IRON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAGE
1D Price
Change %
NAGE100%
-3.62%
IRON - NAGE
45%
Loosely correlated
-2.27%
MDGL - NAGE
45%
Loosely correlated
-0.93%
EPRX - NAGE
34%
Loosely correlated
-0.74%
ADMA - NAGE
32%
Poorly correlated
+0.03%
VIR - NAGE
31%
Poorly correlated
-6.72%
More